Upregulation	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
receptors	O
is	O
associated	O
with	O
advanced	O
neuroblastoma	B-Cancer
.	O

BACKGROUND	O
:	O
Angiogenesis	O
is	O
essential	O
for	O
tumor	B-Cancer
growth	O
and	O
relies	O
on	O
the	O
production	O
of	O
angiogenic	O
factors	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
a	O
major	O
regulator	O
of	O
angiogenesis	O
that	O
binds	O
to	O
tyrosine	O
kinase	O
receptors	O
Flt	O
-	O
1	O
and	O
KDR	O
.	O

The	O
interaction	O
of	O
VEGF	O
and	O
its	O
receptors	O
at	O
gene	O
and	O
protein	O
levels	O
in	O
neuroblastoma	B-Cancer
remains	O
widely	O
unknown	O
.	O

METHODS	O
:	O
Tumor	B-Cancer
biopsy	I-Cancer
specimens	I-Cancer
and	O
serum	B-Organism_substance
were	O
obtained	O
from	O
37	O
neuroblastoma	B-Cancer
patients	O
;	O
adrenal	B-Multi-tissue_structure
biopsy	I-Multi-tissue_structure
sections	I-Multi-tissue_structure
and	O
sera	B-Organism_substance
of	O
7	O
normal	O
children	O
served	O
as	O
controls	O
.	O

Biopsy	B-Cancer
specimens	I-Cancer
were	O
examined	O
by	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
Western	O
blotting	O
;	O
serum	B-Organism_substance
was	O
analyzed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
.	O

VEGF	O
-	O
A	O
(	O
165	O
)	O
,	O
B	O
,	O
C	O
,	O
Flt	O
-	O
1	O
,	O
and	O
KDR	O
were	O
analyzed	O
.	O

RESULTS	O
:	O
VEGF	O
isoforms	O
and	O
its	O
receptors	O
'	O
mRNA	O
were	O
expressed	O
in	O
neuroblastoma	B-Cancer
and	O
control	O
tissues	B-Tissue
.	O

Whereas	O
the	O
ligands	O
were	O
increased	O
in	O
stages	O
III	O
and	O
IV	O
,	O
the	O
receptors	O
were	O
upregulated	O
in	O
stage	O
III	O
only	O
.	O

At	O
protein	O
level	O
,	O
VEGF	O
-	O
B	O
and	O
C	O
,	O
Flt	O
-	O
1	O
,	O
and	O
KDR	O
were	O
not	O
detectable	O
in	O
tissue	B-Organism_substance
lysates	I-Organism_substance
,	O
whereas	O
VEGF	O
-	O
A	O
was	O
increased	O
in	O
stages	O
III	O
and	O
IV	O
.	O

Serum	B-Organism_substance
VEGF	O
protein	O
levels	O
were	O
upregulated	O
in	O
stage	O
III	O
.	O

CONCLUSIONS	O
:	O
VEGF	O
-	O
A	O
(	O
165	O
)	O
is	O
one	O
of	O
the	O
major	O
angiogenesis	O
regulators	O
among	O
the	O
ligands	O
'	O
family	O
of	O
VEGF	O
,	O
whereas	O
its	O
receptors	O
KDR	O
,	O
and	O
most	O
probably	O
Flt	O
-	O
1	O
,	O
may	O
contribute	O
to	O
a	O
poor	O
prognosis	O
(	O
angiogenic	O
)	O
phenotype	O
,	O
as	O
indicated	O
by	O
their	O
upregulated	O
MRNA	O
levels	O
in	O
stage	B-Cancer
III	I-Cancer
neuroblastoma	I-Cancer
.	O

VEGF	O
-	O
A	O
(	O
165	O
)	O
mainly	O
contributes	O
to	O
increased	O
serum	B-Organism_substance
VEGF	O
levels	O
and	O
may	O
serve	O
as	O
a	O
diagnostic	O
tool	O
in	O
advanced	O
-	O
stage	O
neuroblastoma	B-Cancer
.	O

